Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SUNSTONE LIFE SCIENCE VENTURES A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   9.8% 3.7% 2.8% 2.2% 1.4% 1.2% 8.6% 8.5%   Credit score (0-100)   27 53 59 65 77 80 28 29   Credit rating   BB BBB BBB BBB A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.5 87.3 273.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   8,580 23,022 24,136 19,891 16,717 15,918 15,918 15,918   Gross profit   2,200 13,994 16,730 14,349 11,281 10,348 0.0 0.0   EBITDA   -2,243 4,576 4,319 5,141 2,799 3,162 0.0 0.0   EBIT   -2,278 4,495 4,117 4,933 2,634 3,022 0.0 0.0   Pre-tax profit (PTP)   -2,266.0 4,524.0 4,160.0 4,930.0 2,683.0 3,268.0 0.0 0.0   Net earnings   -1,763.0 3,560.0 3,259.0 3,859.0 2,100.0 2,563.0 0.0 0.0   Pre-tax profit without non-rec. items   -2,266 4,524 4,160 4,930 2,683 3,268 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   82.0 477 659 449 283 169 0.0 0.0   Shareholders equity total   822 4,382 4,641 6,500 6,600 7,163 5,558 5,558   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,546 6,826 12,631 8,776 8,239 9,146 5,558 5,558   Net Debt   -711 -2,469 -10,523 -6,024 -6,057 -6,271 -5,558 -5,558     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   8,580 23,022 24,136 19,891 16,717 15,918 15,918 15,918   Net sales growth   -16.4% 168.3% 4.8% -17.6% -16.0% -4.8% 0.0% 0.0%   Gross profit   2,200 13,994 16,730 14,349 11,281 10,348 0.0 0.0   Gross profit growth   -29.6% 536.1% 19.6% -14.2% -21.4% -8.3% -100.0% 0.0%   Employees   7 6 8 8 9 9 0 0   Employee growth %   0.0% -14.3% 33.3% 0.0% 12.5% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,546 6,826 12,631 8,776 8,239 9,146 5,558 5,558   Balance sheet change%   -28.5% 168.1% 85.0% -30.5% -6.1% 11.0% -39.2% 0.0%   Added value   -2,243.0 4,576.0 4,319.0 5,141.0 2,842.0 3,162.0 0.0 0.0   Added value %   -26.1% 19.9% 17.9% 25.8% 17.0% 19.9% 0.0% 0.0%   Investments   22 314 -20 -418 -331 -254 -169 0   Net sales trend   -2.0 1.0 2.0 -1.0 -2.0 -3.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   -26.1% 19.9% 17.9% 25.8% 16.7% 19.9% 0.0% 0.0%   EBIT %   -26.6% 19.5% 17.1% 24.8% 15.8% 19.0% 0.0% 0.0%   EBIT to gross profit (%)   -103.5% 32.1% 24.6% 34.4% 23.3% 29.2% 0.0% 0.0%   Net Earnings %   -20.5% 15.5% 13.5% 19.4% 12.6% 16.1% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -20.1% 15.8% 14.3% 20.4% 13.5% 17.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   -26.4% 19.7% 17.2% 24.8% 16.0% 20.5% 0.0% 0.0%   ROA %   -72.9% 97.7% 43.4% 46.8% 32.1% 37.7% 0.0% 0.0%   ROI %   -130.7% 175.5% 93.4% 89.9% 41.7% 47.7% 0.0% 0.0%   ROE %   -103.5% 136.8% 72.2% 69.3% 32.1% 37.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   32.3% 64.2% 36.7% 74.1% 80.1% 78.3% 100.0% 100.0%   Relative indebtedness %   20.1% 10.6% 33.1% 11.4% 9.8% 12.5% 0.0% 0.0%   Relative net indebtedness %   11.8% -0.2% -10.5% -18.8% -26.4% -26.9% -34.9% -34.9%   Net int. bear. debt to EBITDA, %   31.7% -54.0% -243.6% -117.2% -216.4% -198.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.2 2.3 1.4 3.4 4.4 4.1 0.0 0.0   Current Ratio   1.2 2.3 1.4 3.4 4.4 4.1 0.0 0.0   Cash and cash equivalent   711.0 2,469.0 10,523.0 6,024.0 6,057.0 6,271.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   24.1% 24.6% 46.5% 38.4% 43.1% 51.1% 34.9% 34.9%   Net working capital   346.0 3,240.0 3,240.0 5,367.0 5,561.0 6,151.0 0.0 0.0   Net working capital %   4.0% 14.1% 13.4% 27.0% 33.3% 38.6% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   1,226 3,837 3,017 2,486 1,857 1,769 0 0   Added value / employee   -320 763 540 643 316 351 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -320 763 540 643 311 351 0 0   EBIT / employee   -325 749 515 617 293 336 0 0   Net earnings / employee   -252 593 407 482 233 285 0 0